Immunogenicity of factor VIII concentrates in patients with hemophilia: a randomized clinical trial is warranted.
Gringeri
Alessandro
A
Mannucci
Pier Mannuccio
PM
D000906:Antibodies / Q000276:immunology; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000276:immunology* / Q000627:therapeutic use; D014841:von Willebrand Factor / Q000276:immunology*
D000906:Antibodies; D011994:Recombinant Proteins; D014841:von Willebrand Factor; D005169:Factor VIII